Drug news
Seroquel XR (AstraZeneca) is declared invalid by German Federal Court
The Federal Patent Court in Germany has found the formulation patent protecting Seroquel XR (quetiapine fumarate) prolonged-release tablets � marketed as Seroquel Prolong in Germany by Astra Zeneca � to be invalid. The patent was challenged by Accord Healthcare .Total sales of Seroquel XR in Germany for the ten months ended 31 October 2012 were $82 million.